Steen Meier Rønborg
Corporate Officer/Principal bei University of Copenhagen
Aktive Positionen von Steen Meier Rønborg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Copenhagen | Corporate Officer/Principal | 03.07.2009 | - |
Karriereverlauf von Steen Meier Rønborg
Ehemalige bekannte Positionen von Steen Meier Rønborg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Alsensa ApS
Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market. | Verwaltungsdirektor | 15.04.2010 | 28.06.2012 |
Direktor/Vorstandsmitglied | 02.07.2009 | 15.04.2010 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.10.2000 | 02.07.2009 | |
Gründer | 15.04.2010 | 15.04.2010 | |
Präsident | 01.10.2000 | 02.07.2009 |
Ausbildung von Steen Meier Rønborg
University of Copenhagen | Doctorate Degree |
Statistik
International
Dänemark | 3 |
Operativ
Chief Administrative Officer | 1 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Alsensa ApS
Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market. | Commercial Services |
- Börse
- Insiders
- Steen Meier Rønborg
- Erfahrung